Genomic amplification of the PIK3CA (p110-α) gene was also documented in several lung cancers and in pre-invasive bronchial lesions, implicating the PI3K/AKT pathway in lung cancer development [44]. This evidence concerns the gene PIK3CA and lung carcinoma.